375 related articles for article (PubMed ID: 22691208)
1. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
Bandinelli F; Del Rosso A; Gabrielli A; Giacomelli R; Bartoli F; Guiducci S; Matucci Cerinic M
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S44-9. PubMed ID: 22691208
[TBL] [Abstract][Full Text] [Related]
2. Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute ischaemic stroke.
Zaremba J; Ilkowski J; Losy J
Folia Neuropathol; 2006; 44(4):282-9. PubMed ID: 17183455
[TBL] [Abstract][Full Text] [Related]
3. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity.
Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL
J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768
[TBL] [Abstract][Full Text] [Related]
4. A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C.
Florholmen J; Kristiansen MG; Steigen SE; Sørbye SW; Paulssen EJ; Kvamme JM; Konopski Z; Gutteberg T; Goll R
Clin Microbiol Infect; 2011 Feb; 17(2):204-9. PubMed ID: 20219081
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of chemokines in acute myocardial infarction.
Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of beta-chemokines in systemic lupus erythematosus.
Kaneko H; Ogasawara H; Naito T; Akimoto H; Lee S; Hishikawa T; Sekigawa I; Tokano Y; Takasaki Y; Hirose SI; Hashimoto H
J Rheumatol; 1999 Mar; 26(3):568-73. PubMed ID: 10090164
[TBL] [Abstract][Full Text] [Related]
7. Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.
de Jager SC; Bongaerts BW; Weber M; Kraaijeveld AO; Rousch M; Dimmeler S; van Dieijen-Visser MP; Cleutjens KB; Nelemans PJ; van Berkel TJ; Biessen EA
PLoS One; 2012; 7(9):e45804. PubMed ID: 23029252
[TBL] [Abstract][Full Text] [Related]
8. Circulating chemokines in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and cardiovascular outcome.
Cheng JM; Oemrawsingh RM; Akkerhuis KM; Garcia-Garcia HM; de Boer SP; Battes LC; Buljubasic N; Lenzen MJ; de Jaegere PP; van Geuns RJ; Serruys PW; Kardys I; Boersma E
Biomarkers; 2014 Nov; 19(7):611-9. PubMed ID: 25196123
[TBL] [Abstract][Full Text] [Related]
9. Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients.
Jamali Z; Nazari M; Khoramdelazad H; Hakimizadeh E; Mahmoodi M; Karimabad MN; Hassanshahi G; Rezaeian M; Balaei P; Darakhshan S; Poor NM
Clin Lab; 2013; 59(9-10):993-1001. PubMed ID: 24273921
[TBL] [Abstract][Full Text] [Related]
10. C-C motif chemokine ligand (CCL) production in equine peripheral blood mononuclear cells identified by newly generated monoclonal antibodies.
Schnabel CL; Wemette M; Babasyan S; Freer H; Baldwin C; Wagner B
Vet Immunol Immunopathol; 2018 Oct; 204():28-39. PubMed ID: 30596378
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
12. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
Hasegawa M; Sato S; Takehara K
Clin Exp Immunol; 1999 Jul; 117(1):159-65. PubMed ID: 10403930
[TBL] [Abstract][Full Text] [Related]
13. Assessment of chemokine serum levels in epithelial ovarian cancer patients.
Falcão-Júnior JO; Teixeira-Carvalho A; Cândido EB; Lages EL; Ferreira Freitas G G; Lamaita RM; Freire Bonfim LP; Borges Salera R; Traiman P P; da Silva-Filho AL
Tumori; 2013; 99(4):540-4. PubMed ID: 24326845
[TBL] [Abstract][Full Text] [Related]
14. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Res; 2008; 122(3):328-35. PubMed ID: 18048089
[TBL] [Abstract][Full Text] [Related]
15. Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir.
Bisset LR; Rothen M; Joller-Jemelka HI; Dubs RW; Grob PJ; Opravil M
AIDS; 1997 Mar; 11(4):485-91. PubMed ID: 9084796
[TBL] [Abstract][Full Text] [Related]
16. Effects of peritoneal fluid from endometriosis patients on the release of monocyte-specific chemokines by leukocytes.
Na YJ; Lee DH; Kim SC; Joo JK; Wang JW; Jin JO; Kwak JY; Lee KS
Arch Gynecol Obstet; 2011 Jun; 283(6):1333-41. PubMed ID: 20617440
[TBL] [Abstract][Full Text] [Related]
17. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE.
Adamus G; Manczak M; Machnicki M
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2894-903. PubMed ID: 11687534
[TBL] [Abstract][Full Text] [Related]
18. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Yalçinkaya Y; Çinar S; Artim-Esen B; Kamali S; Öcal L; Deniz G; Inanç M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):110-114. PubMed ID: 27749243
[TBL] [Abstract][Full Text] [Related]
19. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid inhibits chemokines production in systemic sclerosis patients.
Dantas AT; de Almeida AR; Sampaio MCPD; Cordeiro MF; da Rocha LF; de Oliveira PSS; Pereira MC; de Melo Rego MJB; Marques CDL; da Rocha Pitta I; Duarte ALBP; da Rocha Pitta MG
Steroids; 2017 Nov; 127():24-30. PubMed ID: 28866045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]